Abstract:Objective: To study the role of high-mobility group protein 1 (HMGB1) in the promotion of diethylnitrosamine-induced liver cancer formation in C57BL/6 mice and its mechanism. Methods: HMGB1(loxp/loxp)/Alb-Cre(+/-) were used as a liver-specific knockout (KO) of HMGB1 gene in mice. HMGB1(loxp/loxp)/Alb-Cre(-/-), HMGB1(loxp/WT)/Alb-Cre(+/-) and HMGB1(loxp/WT)/Alb-Cre(-/-) born in the same litter were wild-type mice. Six 12-day-old male WT and KO mice were separated and given a single intraperitoneal injection of diethylnitrosamine (25 mg/kg). Six months later, HE staining was used to evaluate the histopathological changes and then the incidence of liver cancer in each mice group was calculated. Serum samples were taken from each mice group to determine alanine aminotransferase levels. Immunohistochemical staining was used to detect the expression and intracellular localizations of HMGB1 protein status in tumor tissue of the two groups of mice. Western blot was used to detect the expressional condition of mitochondrial biogenesis in tumor tissue of the two groups of mice. RT-PCR was used to detect mitochondrial DNA copy number of tumor tissue and normal liver tissue in the two groups of mice. Intra and inter group data comparison was compared using t-tests and one one-way analysis of variance. Results: Compared with WT mice, the liver/body weight ratio of KO mice was decreased significantly (t = 2.634, P = 0.0225). Serum alanine aminotransferase levels in both groups of mice were increased, and the difference was not statistically significant (t = 0.4062, P = 0.6932). There were many visible gray-white nodules of different sizes on the liver surface of WT mice, and the histological type was hepatocellular carcinoma. There was no statistically significant difference in the incidence of liver cancer among different genotypes of WT mice (P > 0.05). The incidence rate of liver cancer in KO mice was significantly reduced (t = 8.521, P < 0.001). Compared with WT mice, the expression levels of HMGB1 and mitochondrial biogenesis (PGC-1α and NRF1) was significantly reduced (t = 6.238, 4.852, P = 0.0335, 0.041) in tumor tissue of KO mice. Mitochondrial DNA copy number was decreased significantly (t = 9.211, P < 0.01). Mitochondrial DNA copy number in tumor tissue of WT mice was significantly higher than that in normal liver tissue (t = 8.305, P = 0.0142). Conclusion: HMGB1 promotes the formation of diethylnitrosamine-induced liver cancer by inducing mitochondrial biogenesis.

Overexpression of HMGB1 in Hepatocytes Accelerates PTEN Inactivation-Induced Liver Cancer

MNS1 Promotes Hepatocarcinogenesis and Metastasis Via Activating PI3K/AKT by Translocating Β‐catenin and Predicts Poor Prognosis

CRISPR/Cas9-mediated P53 and Pten Dual Mutation Accelerates Hepatocarcinogenesis in Adult Hepatitis B Virus Transgenic Mice

Ablation of High‐mobility Group Box‐1 in the Liver Reduces Hepatocellular Carcinoma but Causes Hyperbilirubinemia in Hippo Signaling‐deficient Mice

Excessive Activation of HOXB13/PIMREG Axis Promotes Hepatocellular Carcinoma Progression and Drug Resistance

Identifying the Crucial Biomarker of MASH-Related HCC

[High-mobility group protein 1 promotes diethylnitrosamine-induced liver cancer formation in mice by activating mitochondrial biogenesis]

Expression and Clinical Significance of HMGB1 in Human Liver Cancer: Knockdown Inhibits Tumor Growth and Metastasis in Vitro and in Vivo.

Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model

HBX Suppresses PTEN to Promote the Malignant Progression of Hepatocellular Carcinoma Through Mi-R155 Activation.

Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction.

Transcription Coactivator PBP/MED1-deficient Hepatocytes Are Not Susceptible to Diethylnitrosamine-Induced Hepatocarcinogenesis in the Mouse

High Mobility Group Protein B1 Controls Liver Cancer Initiation Through Yes‐associated Protein ‐dependent Aerobic Glycolysis

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

GPNMB+ Gal-3+ Hepatic Parenchymal Cells Promote Immunosuppression and Hepatocellular Carcinogenesis.

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH

HAF prevents hepatocyte apoptosis and progression to MASH and hepatocellular carcinoma through transcriptional regulation of the NF-κB pathway

Data from MPHOSPH1: A Potential Therapeutic Target for Hepatocellular Carcinoma

Hepatocellular carcinoma induced by hepatocyte Pten deletion reduces BAT UCP-1 and thermogenic capacity in mice, despite increasing serum FGF-21 and iWAT browning

PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression